The new app allows for fully accredited multimedia CME content such as treatment updates, conference highlights, and tests.
Browsing: Uncategorized
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard.
A new genetic discovery could lead to easier detection of colorectal cancer.
Clarient has launched a new gene mutation test to help physicians select the appropriate therapy for non-small cell lung cancer.
VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2 diabetes.
Electro-Optical Sciences anounced that it has submitted a Premarket Approval Application to the U.S. Food and Drug Administration for MelaFind.
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.